Cardiac resynchronization therapy: The state of the art

Expert Review of Cardiovascular Therapy

Volumn 12, Issue 5, 2014, Pages 573-587

  Madias, Christopher ^a   Trohman, Richard G ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

AV optimization; heart failure; remodeling; resynchronization; VV optimization

Indexed keywords

ALGORITHM; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CONGENITAL HEART DISEASE; DIASTOLIC HEART FAILURE; HEART ATRIUM FIBRILLATION; HEART BUNDLE BRANCH BLOCK; HEART ELECTROPHYSIOLOGY; HEART EXCITATION; HEART LEFT VENTRICLE ENDOCARDIAL PACING; HEART PACING; HEART RIGHT VENTRICLE PACING; HEART VENTRICLE PACING; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEADLESS ULTRASOUND BASED LEFT VENTRICLE ENDOCARDIAL RESYNCHRONIZATION; NONHUMAN; PATIENT SELECTION; PERCUTANEOUS CARDIAC RESYNCHRONIZATION THERAPY; QRS COMPLEX; REVIEW; SYSTOLIC HEART FAILURE; THERAPY EFFECT; ANIMAL; HEART FAILURE; PATHOPHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ALGORITHMS; ANIMALS; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; HEART FAILURE; HUMANS; PATIENT SELECTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84899086741     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2014.909284     Document Type: Review

References (126)

1. Furman S. Early history of cardiac pacing and defibrillation. Indian Pacing Electrophysiol J 2002;2:2-3
2. Sutton RFJ, Linde C, Benditt DG. History of electrical therapy for the heart. Eur Heart J Suppl 2007;9(Suppl I):I3-I10
3. Zoll PM. Resuscitation of the heart in ventricular standstill by external electric stimulation. N Engl J Med 1952;247: 768-71
4. Tyers GF. Optimal electrode implantation site for asynchronous dipolar cardiac pacing. Ann Surg 1968;167:168-79
5. Lemberg L. Castellanos Jr. A, Berkovits BV. Pacemaking on demand in AV block. JAMA 1965;191(1):12-14
6. Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA 2007;298: 1312-22
7. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322-4
8. Matchett M, Sears SF, Hazelton G, et al. The implantable cardioverter defibrillator: its history, current psychological impact and future. Expert Rev Med Devices 2009;6: 43-50
9. Fain ES, Winkle RA. Implantable cardioverter defibrillator: ventritex Cadence. J Cardiovasc Electrophysiol 1993;4:211-23
10. Kleman JM, Castle LW, Kidwell GA, et al. Nonthoracotomy-versus thoracotomy implantable defibrillators. Intention-to-treat comparison of clinical outcomes. Circulation 1994;90:2833-42
11. Burkhoff D, Sagawa K. Influence of pacing site on canine left ventricular force-interval relationship. Am J Physiol 1986;250: H414-18
12. Cohen TJ, Klein J. Cardiac resynchronization therapy for treatment of chronic heart failure. J Invasive Cardiol 2002;14:48-53
13. Grines CL, Bashore TM, Boudoulas H, et al. Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. Circulation 1989;79:845-53
14. Lattuca JJ CT, Mower MM. Biventricular pacing to improve cardiac hemodynamics. Clin Rev 1990;38:882A
15. Cazeau S, Ritter P, Bakdach S, et al. Four chamber pacing in dilated cardiomyopathy. Pacing Clin Electrophysiol 1994;17:1974-9
16. Leclercq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002;39:194-201
17. Daubert JC, Ritter P, Le Breton H, et al. Permanent left ventricular pacing with transvenous leads inserted into the coronary veins. Pacing Clin Electrophysiol 1998; 21(1 Pt 2):239-45
18. Nichols M. European Perspectives. Spotlight: Angelo Auricchio, MD, PhD, FESC. Circulation 2009;120: f85-90
19. Auricchio A, Klein H, Tockman B, et al. Transvenous biventricular pacing for heart failure: can the obstacles be overcome? Am J Cardiol 1999;83: 136D-42D
20. Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013;34(29):2281-329
21. Hobbs R, Boyle A. Heart failure. Available from: www. clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/heart-failure/ [Last] [accessed 16 March 2014]
22. Heart Failure: causes diagnosis and treatment-clinical key. Available from: www.clinicalkey.com/topics/pulmonology/heart-failure.html [Last accessed 16 March 2014]
23. Trohman RG. Current concepts in the management of cardiogenic shock. In press
24. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics- 2014 update: a report from the American Heart Association. Circulation 2013;127(1): e6-e245
25. McMurray JJ. Clinical practice. Systolic heart failure. N Engl J Med 2010;362: 228-38
26. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83
27. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352: 225-37
28. Baldasseroni S, De Biase L, Fresco C, et al. Cumulative effect of complete left bundle-branch block and chronic atrial fibrillation on 1-year mortality and hospitalization in patients with congestive heart failure. A report from the Italian network on congestive heart failure (in-CHF database). Eur Heart J 2002;23:1692-8
29. Abdel-Qadir HM, Tu JV, Austin PC, et al. Bundle branch block patterns and long-term outcomes in heart failure. Int J Cardiol 2011;146:213-18
30. Bilchick KC, Helm RH, Kass DA. Physiology of biventricular pacing. Curr Cardiol Rep 2007;9:358-65
31. Pires LA, Abraham WT, Young JB, Johnson KM; Miracle Investigators M-I. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials. Am Heart J 2006;151:837-43
32. Strauss DG, Selvester RH, Wagner GS. Defining left bundle branch block in the era of cardiac resynchronization therapy. Am J Cardiol 2011;107:927-34
33. Ruschitzka F, Abraham WT, Singh JP, et al. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med 2013;369:1395-405
34. Cho H, Barth AS, Tomaselli GF. Basic science of cardiac resynchronization therapy: molecular and electrophysiological mechanisms. Circ Arrhythm Electrophysiol 2012;5(3):594-603
35. Knaapen P, van Campen LM, de Cock CC, et al. Effects of cardiac resynchronization therapy on myocardial perfusion reserve. Circulation 2004;110(6):646-51
36. Lumens J, Ploux S, Strik M, et al. Comparative electromechanical and hemodynamic effects of left ventricular and biventricular pacing in dyssynchronous heart failure: electrical resynchronization versus left-right ventricular interaction. J Am Coll Cardiol 2013;62(25):2395-403
37. Abraham J, Abraham TP. Is echocardiographic assessment of dyssynchrony useful to select candidates for cardiac resynchronization therapy? Echocardiography is useful before cardiac resynchronization therapy if QRS duration is available. Circulation Cardiovascular imaging 2008;1:79-84; discussion
38. Ritter P, Delnoy PP, Padeletti L, et al. A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods. Europace 2012;14:1324-33
39. Sohaib SM, Chen Z, Whinnett ZI, et al. Meta-analysis of symptomatic response attributable to the pacing component of cardiac resynchronization therapy. Eur J Heart Fail 2013;15(12):1419-28
40. Hsu JC, Solomon SD, Bourgoun M, MADIT-CRT Executive Committee. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. J Am Coll Cardiol 2012;59(25):2366-73
41. Gasparini M, Galimberti P, La Marchesina U, et al. Optimization of cardiac resynchronization therapy: technical aspects. Eur Heart J Suppl 2002; 4(suppl D):D82-D7
42. Shamim W, Francis DP, Yousufuddin M, et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol 1999;70:171-8
43. Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm 2012;9: 1737-53
44. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38
45. Auricchio A, Stellbrink C, Butter C, et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 2003;42:2109-16
46. Tang AS, Wells GA, Talajic M, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;363:2385-95
47. Daubert C, Gold MR, Abraham WT, et al. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J Am Coll Cardiol 2009;54:1837-46
48. Gold MR, Daubert JC, Abraham WT, et al. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE). Circ Arrhythm Electrophysiol 2013;6:1163-8
49. Sipahi I, Carrigan TP, Rowland DY, et al. Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Arch Intern Med 2011;171:1454-62
50. Stavrakis S, Lazzara R, Thadani U. The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis. J Cardiovasc Electrophysiol 2012;23:163-8
51. Cleland JG, Abraham WT, Linde C, et al. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J 2013;34(46):3547-56
52. Guglin M, Curtis AB. Cardiac resynchronization therapy: 150 is not a magic number!. Circ Arrhythm Electrophysiol 2013;6:429-35
53. Gold MR, Thebault C, Linde C, et al. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study. Circulation 2012;126: 822-9
54. Beshai JF, Grimm RA, Nagueh SF, et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med 2007;357:2461-71
55. European Heart Rhythm A, European Society of C, Heart Rhythm S, et al. 2012;EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace 2012;14:1236-86
56. Epstein AE, Dimarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm 2008;5:e1-62
57. Sweeney MO. Wide right. Heart Rhythm 2005;2:616-18
58. Byrne MJ, Helm RH, Daya S, et al. Diminished left ventricular dyssynchrony and impact of resynchronization in failing hearts with right versus left bundle branch block. J Am Coll Cardiol 2007;50: 1484-90
59. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50
60. Egoavil CA, Ho RT, Greenspon AJ, Pavri BB. Cardiac resynchronization therapy in patients with right bundle branch block: analysis of pooled data from the MIRACLE and Contak CD trials. Heart Rhythm 2005;2:611-15
61. Zareba W, Klein H, Cygankiewicz I, et al. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 2011;123:1061-72
62. Bilchick KC, Kamath S, DiMarco JP, Stukenborg GJ. Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients. Circulation 2010;122:2022-30
63. Sipahi I, Chou JC, Hyden M, et al. Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Am Heart J 2012;163: 260-7; e3
64. Prinzen FW, Auricchio A. Is echocardiographic assessment of dyssynchrony useful to select candidates for cardiac resynchronization therapy? Echocardiography is not useful before cardiac resynchronization therapy if QRS duration is available. Circulation Cardiovascular Imaging 2008;1:70-7; discussion 8
65. Gasparini MLC, Lunati M, Landolina M, et al. Cardiac Resynchronization in Patients with Atrial Fibrillation. The CERTIFY study (Cardiac Resynchronization in Atrial Fibrillation Patients Multinational Registry). JACC: Heart Failure 2013;500-7
66. Hayes DL, Boehmer JP, Day JD, et al. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 2011;8:1469-75
67. Strik M, van Middendorp LB, Vernooy K. Animal models of dyssynchrony. J Cardiovasc Transl Res 2012;5: 135-45
68. Fleischmann KE, Orav EJ, Lamas GA, et al. Pacemaker implantation and quality of life in the Mode Selection Trial (MOST). Heart Rhythm 2006;3:653-9
69. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-23
70. Prinzen FW, Peschar M. Relation between the pacing induced sequence of activation and left ventricular pump function in animals. Pacing Clin Electrophysiol 2002;25:484-98
71. Auricchio A, Fantoni C, Regoli F, et al. Characterization of left ventricular activation in patients with heart failure and left bundle-branch block. Circulation 2004;109: 1133-9
72. Rodriguez LM, Timmermans C, Nabar A, et al. Variable patterns of septal activation in patients with left bundle branch block and heart failure. J Cardiovasc Electrophysiol 2003;14:135-41
73. Prinzen FW, Augustijn CH, Arts T, et al. Redistribution of myocardial fiber strain and blood flow by asynchronous activation. Am J Physiol 1990;259:H300-8
74. Prinzen FW, Hunter WC, Wyman BT, McVeigh ER. Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol 1999;33: 1735-42
75. Skalidis EI, Kochiadakis GE, Koukouraki SI, et al. Myocardial perfusion in patients with permanent ventricular pacing and normal coronary arteries. J Am Coll Cardiol 2001;37:124-9
76. Lieberman R, Padeletti L, Schreuder J, et al. Ventricular pacing lead location alters systemic hemodynamics and left ventricular function in patients with and without reduced ejection fraction. J Am Coll Cardiol 2006;48:1634-41
77. Yu CM, Chan JY, Zhang Q, et al. Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med 2009;361:2123-34
78. Curtis AB, Worley SJ, Adamson PB, et al. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med 2013;368:1585-93
79. Barsheshet A, Goldenberg I, Moss AJ, et al. Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT. Eur Heart J 2011;32(13):1622-30
80. Singh JP, Klein HU, Huang DT, et al. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation 2011;123:1159-66
81. Khan FZ, Virdee MS, Palmer CR, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol 2012;59:1509-18
82. Singh JP, Gras D. Biventricular pacing: current trends and future strategies. Eur Heart J 2012;33:305-13
83. Kandala J, Upadhyay GA, Altman RK, et al. QRS morphology, left ventricular lead location, and clinical outcome in patients receiving cardiac resynchronization therapy. Eur Heart J 2013;34:2252-62
84. Gorcsan J 3rd, Abraham T, Agler DA, American Society of Echocardiography Dyssynchrony Writing Group. Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting-a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr 2008;21(3): 191-213
85. Whinnett ZI, Davies JE, Willson K, et al. Haemodynamic effects of changes in atrioventricular and interventricular delay in cardiac resynchronisation therapy show a consistent pattern: analysis of shape, magnitude and relative importance of atrioventricular and interventricular delay. Heart 2006;92(11):1628-34
86. Naqvi TZ. Echocardiography-guided biventricular pacemaker optimization. JACC Cardiovasc Imaging 2010;3(11):1168-80
87. Ellenbogen KA, Gold MR, Meyer TE, et al. Primary results from the Smart Delay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation 2010;122(25):2660-8
88. Martin DO, Lemke B, Birnie D, Adaptive CRT Study Investigators. Investigation of a novel algorithm for synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm 2012;9(11):1807-14
89. Barold S, Mugica J. The fifth decade of cardiac pacing. Wiley; Hoboken, NJ, USA: 2012. p. 23
90. Trohman RG, Kim MH, Pinski SL. Cardiac pacing: the state of the art. Lancet 2004;364:1701-19
91. Levy T, Walker S, Rex S, Paul V. A comparison between passive and active fixation leads in the coronary sinus for biatrial pacing: initial experience. Europace 2000;2:228-32
92. Medtronic® InSync® Biventricular Pacing System including the InSync ®Model 8040 Pulse Generator, Attain™ LV Model 2187 and Attain ™CS Model 2188 Leads P010015. Available from: www.fda.gov/MedicalDevices/ ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently- ApprovedDevices/ucm085388.htm [Last accessed 1 January 2014]
93. Khairy P. Defibrillators and cardiac resynchronization therapy in congenital heart disease: evolving indications. Expert Rev Med Devices 2008;5:267-71
94. Dubin AM, Janousek J, Rhee E, et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol 2005;46:2277-83
95. Krishnan K, Avramovitch NA, Kim MH, Trohman RG. Cardiac resynchronization therapy: a potential option for congenitally corrected transposition of the great vessels. J Heart Lung Transplant 2005;24:2293-6
96. Parikh MG, Halleran SM, Bharati S, Trohman RG. Successful percutaneous cardiac resynchronization despite an occlusive Thebesian valve. Pediatr Cardiol 2011;32:1223-7
97. Jais P, Douard H, Shah DC, et al. Endocardial biventricular pacing. Pacing Clin Electrophysiol 1998;21:2128-31
98. van Gelder BM, Scheffer MG, Meijer A, Bracke FA. Transseptal endocardial left ventricular pacing: an alternative technique for coronary sinus lead placement in cardiac resynchronization therapy. Heart Rhythm 2007;4:454-60
99. Jais P, Takahashi A, Garrigue S, et al. Mid-term follow-up of endocardial biventricular pacing. Pacing Clin Electrophysiol 2000;23:1744-7
100. Gamble JH, Bashir Y, Rajappan K, Betts TR. Left ventricular endocardial pacing via the interventricular septum for cardiac resynchronization therapy: first report. Heart Rhythm 2013;10: 1812-14
101. Allred JD, McElderry HT, Doppalapudi H, et al. Biventricular ICD implantation using the iliofemoral approach: providing CRT to patients with occluded superior venous access. Pacing Clin Electrophysiol 2008;31: 1351-4
102. Gurevitz O, Nof E, Carasso S, et al. Programmable multiple pacing configurations help to overcome high left ventricular pacing thresholds and avoid phrenic nerve stimulation. Pacing Clin Electrophysiol 2005;28:1255-9
103. Murphy JK TR, Suzuki HK, Krishnan K, et al. Are bipolar LV leads really superior? Heart Rhythm 2007;4:S106-7
104. Medtronic Announces CE Mark and European Launch of Attain Performa® Portfolio of Quadripolar Leads. Available from: http://newsroom.medtronic.com/ phoenix.zhtml?c=251324&p=irolnewsArticle& ID=1802650&highlight= [Last accessed 18 March 2014]
105. Boston Scientific Announces CE Mark Approval And First Implants Of Its Next-Generation X4 Quadripolar CRT-D Systems. Available from: http://news. bostonscientific.com/2013-12-17-Boston-Scientific-Announces-CE-Mark-Approval- And-First-Implants-Of-Its-Next-Generation-X4-Quadripolar-CRT-D-Systems [Last accessed 18 March 2014]
106. Bogaard MD, Houthuizen P, Bracke FA, et al. Baseline left ventricular dP/dtmax rather than the acute improvement in dP/dtmax predicts clinical outcome in patients with cardiac resynchronization therapy. Eur J Heart Fail 2011;13:1126-32
107. Duckett SG, Ginks M, Shetty AK, et al. Invasive acute hemodynamic response to guide left ventricular lead implantation predicts chronic remodeling in patients undergoing cardiac resynchronization therapy. J Am Coll Cardiol 2011;58(11): 1128-36
108. Thibault B, Dubuc M, Khairy P, et al. Acute haemodynamic comparison of multisite and biventricular pacing with a quadripolar left ventricular lead. Europace 2013;15(7):984-91
109. Sohaib SM, Whinnett ZI, Ellenbogen KA, Stellbrink C; International Working Group on Quantitative Optimization. Francis Cardiac resynchronisation therapy optimisation strategies: Systematic classification, detailed analysis, minimum standards and a roadmap for development and testing. Int J Cardiol 2013;170(2): 118-31
110. Gras D, Gupta MS, Boulogne E, et al. Optimization of AV and VV delays in the real-world CRT patient population: an international survey on current clinical practice. Pacing Clin Electrophysiol 2009; 32(Suppl 1):S236-9
111. O'Donnell D, Nadurata V, Hamer A, et al. Long-term variations in optimal programming of cardiac resynchronization therapy devices. Pacing Clin Electrophysiol 2005;28(Suppl 1):S24-6
112. Jones RC, Svinarich T, Rubin A, et al. Optimal atrioventricular delay in CRT patients can be approximated using surface electrocardiography and device electrograms. J Cardiovasc Electrophysiol 2010;21: 1226-32
113. Khaykin Y, Exner D, Birnie D, et al. Adjusting the timing of left-ventricular pacing using electrocardiogram and device electrograms. Europace 2011;13: 1464-70
114. Lee KL, Burnes JE, Mullen TJ, et al. Avoidance of right ventricular pacing in cardiac resynchronization therapy improves right ventricular hemodynamics in heart failure patients. J Cardiovasc Electrophysiol 2007;18:497-504
115. van Gelder BM, Bracke FA, Meijer A, Pijls NH. The hemodynamic effect of intrinsic conduction during left ventricular pacing as compared to biventricular pacing. J Am Coll Cardiol 2005;46:2305-10
116. Birnie DH, Tang AS. If it is not broken, don't fix it: avoidance of right ventricular pacing in cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2007;18:505-6
117. VIVA™ CRT-D Reference Manual. Available from: http://manuals. medtronic.com/wcm/groups/mdtcom-sg/@emanuals/@era/@crdm/documents/documents/ contrib-166529.pdf. [Last accessed 4 August 2014]
118. Singh JP, Abraham WT, Chung ES, et al. Clinical response with adaptive CRT algorithm compared with CRT with echocardiography-optimized atrioventricular delay: a retrospective analysis of multicentre trials. Europace 2013;15:1622-8
119. Eitel C, Gaspar T, Bode K, et al. Temporary left ventricular stimulation in patients with refractory cardiogenic shock and asynchronous left ventricular contraction: a safety and feasibility study. Heart Rhythm 2013;10:46-52
120. Trohman RG. Temporary left ventricular resynchronization therapy in cardiogenic shock: a new pacing paradigm to fight an old foe? Heart Rhythm 2013;10:53-4
121. van Deursen C, van Geldorp IE, Rademakers LM, et al. Left ventricular endocardial pacing improves resynchronization therapy in canine left bundle-branch hearts. Circ Arrhythm Electrophysiol 2009;2:580-7
122. Derval N, Steendijk P, Gula LJ, et al. Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites: the lateral left ventricular wall and the coronary sinus are rarely the best sites. J Am Coll Cardiol 2010;55(6):566-75
123. Regoli F, Auricchio A. The role of invasive mapping in the electrophysiology laboratory. Europace 2009;11(Suppl 5):v40-5
124. Bordachar P, Derval N, Ploux S, et al. Left ventricular endocardial stimulation for severe heart failure. J Am Coll Cardiol 2010;56(10):747-53
125. Trohman RG, Wilkoff BL, Byrne T, Cook S. Successful percutaneous extraction of a chronic left ventricular pacing lead. Pacing Clin Electrophysiol 1991;14(10):1448-51
126. Auricchio A, Delnoy PP, Butter C, for the Collaborative Study Group. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the Wireless Stimulation Endocardially for CRT (WiSE-CRT) study. Europace 2014. [Epub ahead of print]